bpc-157 source Peptide BPC-157 | 99%+ Purity |

GHK-Cu is commonly administered subcutaneously

Selecting the appropriate quantity depends on the scale and duration of the research programme: GHK-CU 50mg is suited to smaller-scale studies, preliminary investigations, method development, and research programmes that are in the early stages of incorporating this compound into their experimental design

Get out of the heat and into an air-conditioned space or a cool, shaded area

Pre-clinical rodent models of tendon rupture have shown combined BPC-157 and TB-500 protocols to produce faster return of tensile strength and superior histological organisation compared to either single-peptide treatment or untreated controls

Secher A, Lutz TA, Raun K

This study was funded by a 2024 EG grant (CIGE/2023/100) from Conselleria de Educacin, Cultura, Universidades y Empleo (Valencia, Spain)